Sulforaphane to Reduce Symptoms of Schizophrenia

Clinical trial NCT02810964 · COMPLETED

Trial details

NCT number: NCT02810964
Sponsor: Sheppard Pratt Health System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2017-02-22
Primary completion: 2019-11-11
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.